InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Fischer Laurent, Chairman & CEO. Officer active across 1 company, notably Adverum Biotechnologies, Inc.. Aggregated, 9 disclosures have been published. Split: 3 buys · 3 sells. Total volume traded: €150k. Activity tracked since 6 August 2021. The latest transaction was disclosed on 15 May 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations9 total
9,126 shares@ US$2.0010.9% of flowCommon StockSEC:0001415889-25-013442:0
25,000 shares0Common StockSEC:0001415889-25-005833:0
41,239 shares@ US$0.781620.1% of flowCommon StockSEC:0001209191-23-019835:0
41,082 shares@ US$1.069629.3% of flowCommon StockSEC:0001209191-22-050951:0
25,000 shares@ US$1.11243.0% of flowCommon StockSEC:0001209191-22-025414:0
Ideal exit: 15 Jan 2023 (T+270)
10,677 shares@ US$1.7911.3% of flowCommon StockSEC:0001209191-21-069099
Ideal exit: 4 Sept 2022 (T+270)
10,677 shares@ US$1.7928.5% of flowCommon StockSEC:0001209191-21-069099:0
Ideal exit: 4 Sept 2022 (T+270)
680,000 shares0Common StockSEC:0001209191-21-050747:0
680,000 shares0Common StockSEC:0001209191-21-050747
9 of 9 declarations
About Fischer Laurent
Laurent Fischer is the CEO, President, and Director of Adverum Biotechnologies, Inc. He leads the company with a vision focused on innovation in the biotechnology field. His leadership is crucial for Adverum's growth, ensuring that the company remains at the forefront of therapeutic advancements.
